Search results
Historic Shift in U.S. Drug Policy: DEA Proposes to Reclassify Marijuana | JD Supra
JD Supra· 2 days agoThe U.S. Drug Enforcement Administration (DEA) is on the brink of reclassifying marijuana, marking a watershed moment in American < ...
From Discretion to Regulation: FDA's New Path for LDTs | JD Supra
JD Supra· 9 hours agoEarlier this year, we reported on the expected U.S. Food and Drug Administration (FDA) ruling concerning Laboratory Developed Tests ( ...
Marijuana reclassification could clear hurdles for NJ businesses
NJBIZ· 3 days agoThe U.S. Drug Enforcement Administration is taking steps to reclassify marijuana as a lower-risk...
Teva Pharm Q1 profit misses estimates, revenue rises By Reuters
Investing.com· 5 hours agoTeva Pharmaceutical Industries (NYSE:TEVA) reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales of copycat medicines and its ...
Central Oregon cannabis industry keeping an eye on DEA actions
The Bulletin· 6 days agoCentral Oregon cannabis producers, retailers and manufacturers are hopeful that the U.S. Drug...
Reclassification of cannabis
UB Reporter· 9 hours agoThe U.S. Drug Enforcement Administration’s move to reclassify cannabis from a Schedule I to a Schedule III substance has broad implications ...
Healthcare and drugmaker groups seek to revive challenge to US drug-pricing law
Reuters· 7 days agoHealthcare and drug industry groups on Wednesday urged a U.S. appeals court to revive their...
Secretary of State Antony J. Blinken Tours Antheia, Discusses the Importance of Biotechnology...
The Grass Valley Union· 2 days agoVisit demonstrates U.S. commitment to bolstering the domestic biotechnology industry and onshoring critical supply chains, including pharmaceuticals
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 5 hours agoThe company's financials are among the best on Wall Street, and it is one of two public companies...
Radyus Research and Dt&CRO Join Forces to Pave Way for South Korean Biotech Companies into the U.S....
New Bern Sun Journal· 24 hours agoRadyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Dt&CRO, a leading South Korean contract ...
